Chiesa R (2026). [PMID: 41363805](https://pubmed.ncbi.nlm.nih.gov/41363805/). *N Engl J Med*. [Clinical Trial Publication]
Te Vrugt M (2025). [PMID: 40808247](https://pubmed.ncbi.nlm.nih.gov/40808247/). *Br J Haematol*. [Review / Meta-Analysis]
Luskin MR (2025). [PMID: 39546748](https://pubmed.ncbi.nlm.nih.gov/39546748/). *Blood Adv*. [Clinical Trial Publication]
Dulery R (2025). [PMID: 39779930](https://pubmed.ncbi.nlm.nih.gov/39779930/). *Nat Med*. [Epidemiology / Natural History]
Adomako J (2025). [PMID: 40413101](https://pubmed.ncbi.nlm.nih.gov/40413101/). *Trends Mol Med*. [Review / Meta-Analysis]
E S (2025). [PMID: 40318961](https://pubmed.ncbi.nlm.nih.gov/40318961/). *Pathology*. [Basic Science / Preclinical]
Kantarjian H (2025). [PMID: 40759141](https://pubmed.ncbi.nlm.nih.gov/40759141/). *Lancet*. [Review / Meta-Analysis]
Summers RJ (2025). [PMID: 38364183](https://pubmed.ncbi.nlm.nih.gov/38364183/). *Blood*. [Review / Meta-Analysis]
Zhang M (2025). [PMID: 40244598](https://pubmed.ncbi.nlm.nih.gov/40244598/). *JAMA Oncol*. [Clinical Trial Publication]
Xu J (2025). [PMID: 41348046](https://pubmed.ncbi.nlm.nih.gov/41348046/). *Hematology Am Soc Hematol Educ Program*. [Review / Meta-Analysis]
